Table 1 The characteristics of the DLBCL patients in GEO datasets.
Characteristic | Training cohort GSE31312 (n = 471) | Validation cohort 1 GSE87371 (n = 122) | Validation cohort 2 GSE10846 (n = 233) |
|---|---|---|---|
Gender | |||
Male/female | 271/200 | 59/63 | 134/99 |
Age (year) | |||
Mean (range) | 61.86 (18–92) | 63.36 (20–87) | 60.16 (17–92) |
≥ 60 | 285 (60.51%) | 100 (81.97%) | 124 (53.22%) |
< 60 | 186 (39.49) | 22 (18.03%) | 109 (46.78%) |
(COO) subtypes | |||
ABC | 200 (42.46%) | 56 (45.90%) | 93 (39.91%) |
GCB | 227 (48.20%) | 42 (34.43%) | 107 (45.92%) |
Other | 44 (9.34%) | 24 (19.67%) | 33 (14.16%) |
IPI | |||
≥ 2 | 255 (54.14%) | 104 (85.25%) | – |
< 2 | 170 (36.09%) | 18 (14.75%) | – |
NA | 46 (9.77%) | – | – |
Stage | |||
I–II | – | 24 (19.67%) | 105 (45.06%) |
III–IV | – | 98 (80.33%) | 121 (51.93%) |
NA | – | – | 7 (3.00%) |
